Diazeniumdiolates spontaneously release nitric oxide (NO) in aqueous solutions. Therefore, protected diazeniumdiolates have been developed for the controlled administration of NO to specific targets. Diazeniumdiolates with photoprotecting groups are useful for spatiotemporal NO delivery. To develop photoactivated NO donors, understanding the photodissociation dynamics of photoprotected diazeniumdiolates is essential. The dynamics of photoexcited V-PYRRO/NO (a well-studied liver-selective NO prodrug) was investigated to understand the photodissociation mechanism of protected diazeniumdiolates at the molecular level. Upon excitation at 305 nm, the N�N bond of V-PYRRO/NO was cleaved within 0.3 ps, producing Nnitrosopyrrolidine and CH 2 �CHON. CH 2 �CHON, the first oxynitrene directly observed in the solution in real-time, was formed in the singlet state and rearranged into CH 2 �CHNO with a time constant of 16 ± 5 ns. The calculated potential energy surfaces of the excited states confirmed the unusual breakage of the N�N bond. The findings can be utilized to develop more effective photoactivated diazeniumdiolates.N itric oxide (NO) plays a crucial role in various physiological processes, including vasodilation, inflammation modulation, and blood pressure regulation. 1−3 Diazeniumdiolates (R 2 N−N(O)=NO − ), also known as NON-Oates, are useful for delivering NO in biological systems. 3−7 These compounds are formed by the reaction between amines and NO gas under high pressures and are capable of spontaneously releasing NO under physiological conditions. 5,8 Diazeniumdiolates have been developed with half-lives ranging between 2 s and 20 h in aqueous buffer at a pH of 7.4 and 37 °C. 9 However, controlling the release of NO remains challenging; particularly, it is difficult to modify the structure to achieve a targeted and sustained release of NO, which is critical in therapeutic applications. 10,11 Caged diazeniumdiolates, which are formed by the attachment of alkyl groups to the oxygen atom of diazeniumdiolates, prevent premature NO release. 12−16 This protective mechanism can be removed via photochemical reactions, creating the potential for light-activated NO donors. 16,17 These systems enable the spatiotemporal control of NO-delivery, which is advantageous for various clinical applications. 11,18,19 Numerous protective groups have been investigated for caging diazeniumdiolates. However, many caged diazeniumdiolates undergo two distinct photoreaction pathways (Scheme 1): 16 one pathway produces the desirable diazeniumdiolate by dissociating the protecting group (Path A in Scheme 1), whereas the other leads to the undesired breakdown of the N�N bond producing potentially carcinogenic nitrosamines (Path B in